Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,304 across all filing types
Latest filing 2022-01-04 Declaration of Voting R…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (London Stock Exchange's news service), indicated by the 'RNS Number' and the closing statement referencing RNS as the Primary Information Provider. The content explicitly states the 'total number of voting rights' as of a specific date (31 December 2021) and references the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of filing, which reports on the total issued share capital and voting rights, is a specific regulatory disclosure. While it relates to capital structure, it is not a general financing announcement (CAP) or a major shareholding change notification (MRQ). It is a mandatory regulatory disclosure that doesn't fit the specific categories like AGM-R, 10-K, or ER. Given the nature of mandatory regulatory updates that don't fit other specific codes, the most appropriate classification is the general regulatory filing category, RNS, as it is distributed via the RNS system and serves as a regulatory update.
2022-01-04 English
ASTRAZENECA AND IONIS CLOSE EPLONTERSEN DEAL
Foreign Filer Report
2021-12-29 English
AstraZeneca and Ionis close eplontersen deal
M&A Activity Classification · 99% confidence The document begins with 'RNS Number' and is dated '29 December 2021'. It announces a specific corporate event: 'AstraZeneca and Ionis close agreement to develop and commercialise eplontersen', detailing financial considerations and strategic implications. This format, originating from RNS (the news service of the London Stock Exchange) and covering a specific, non-periodic corporate action (like a partnership or M&A component), strongly suggests a general regulatory announcement. Since it is not a standard periodic report (10-K, IR, ER), nor a specific filing like Director's Dealing (DIRS) or Dividend Notice (DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2021-12-29 English
ULTOMIRIS ACCEPTED FOR FDA PRIORITY REVIEW FOR GMG
Foreign Filer Report
2021-12-21 English
Ultomiris accepted for FDA Priority Review for gMG
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 3208W' and is dated '21 December 2021'. It announces regulatory news regarding an FDA Priority Review acceptance for a supplemental Biologics License Application (sBLA) for Ultomiris. The text concludes with standard disclaimers and contact information related to RNS (the news service of the London Stock Exchange) and the FCA. This format is characteristic of a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like a 10-K, ER, or IR. Since it is a regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback is RNS.
2021-12-21 English
TEZSPIRE APPROVED IN THE US FOR SEVERE ASTHMA
Foreign Filer Report
2021-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.